Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Maravai LifeSciences Holdings, Inc. (MRVI) had Gross Margin of 40.14% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$51.44M |
|
$-12.42M |
|
$30.79M |
|
$20.65M |
|
$66.53M |
|
$-15.09M |
|
$-6.71M |
|
$-21.80M |
|
$-21.80M |
|
$-21.63M |
|
$-21.63M |
|
$-21.63M |
|
$-21.63M |
|
$-15.09M |
|
$-1.68M |
|
148.00M |
|
148.00M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$155.66M |
|
$142.41M |
|
$448.09M |
|
$603.75M |
|
$38.42M |
|
$175.57M |
|
$209.74M |
|
$248.16M |
|
$355.59M |
|
$87.78M |
|
$355.59M |
|
259.57M |
|
| Cash Flow Statement Financials | |
$12.66M |
|
$-4.81M |
|
$-154.21M |
|
$216.89M |
|
$70.58M |
|
$-146.31M |
|
$16.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.05 |
|
-- |
|
-- |
|
0.33 |
|
0.50 |
|
|
Gross Margin |
40.14% |
-29.33% |
|
-29.33% |
|
-- |
|
-42.38% |
|
-24.14% |
|
$7.85M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.75 |
|
1.65 |
|
54.48 |
|
-6.08% |
|
-24.64% |
|
-3.58% |
|
-4.07% |
|
$1.37 |
|
$0.05 |
|
$0.09 |
|